Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies
about
The evolution of poxvirus vaccinesDeletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-CNew approaches to design HIV-1 T-cell vaccinesImproving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling PathwaysVirological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.A novel candidate HIV vaccine vector based on the replication deficient Capripoxvirus, Lumpy skin disease virus (LSDV)Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve ImmunogenicitySelection of recombinant MVA by rescue of the essential D4R gene.Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virusDeletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.Enhancing poxvirus vectors vaccine immunogenicity.Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants.Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.Gene therapy for mesothelioma and lung cancer.Gene therapy for mesothelioma.Clinical applications of attenuated MVA poxvirus strain.Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
P2860
Q26995905-4574F89B-EFA6-471F-B05C-41975F94B819Q27306437-CB5653A2-697E-4DC6-A95D-71369CD4ED7CQ34274849-55C91A00-9053-46EE-A3A9-A4AC11BC4C2BQ34796206-4E3300E2-AA65-43FA-AB76-08C1F3381FCFQ34991112-11495507-662E-4822-94A8-3B918E5C4204Q35053133-F14F33D0-D2B3-4E87-969E-150BCDEB5B46Q35571248-14805BF1-3889-4D22-9461-B72572CA7699Q35656345-903BB44C-A118-49CD-B86E-1D3FBA7FD347Q35800430-37656728-1A50-4E76-94D7-2475AC054E97Q35962511-A5C2DBBF-1DBA-47B7-B1AE-951B4BCEB5F0Q36397581-FC372704-8FD6-46D5-8023-E366307F7D0DQ36978452-AD3B437E-136A-4AA9-B96A-764A71EAFB2FQ37209483-A6AB7242-0037-41BF-9B64-1F1A94F502E7Q37643731-A253EE2E-43F3-437A-9A95-022F410CCD46Q37693512-1531E40E-8B1D-4B3A-8E2C-3DD6B62EC1C0Q37868973-00689B4E-E4C2-49EF-AD85-FC82D5D04EA7Q38156198-217C67F2-1A3B-4EB4-8939-78354F017916Q39046601-E830A0FE-690E-4368-B0AB-30ACEE476544
P2860
Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Expanding the repertoire of Mo ...... tic complementation strategies
@ast
Expanding the repertoire of Mo ...... tic complementation strategies
@en
type
label
Expanding the repertoire of Mo ...... tic complementation strategies
@ast
Expanding the repertoire of Mo ...... tic complementation strategies
@en
prefLabel
Expanding the repertoire of Mo ...... tic complementation strategies
@ast
Expanding the repertoire of Mo ...... tic complementation strategies
@en
P2093
P2860
P1433
P1476
Expanding the repertoire of Mo ...... tic complementation strategies
@en
P2093
David A Garber
Leigh A O'Mara
Mark B Feinberg
Sailaja Gangadhara
P2860
P356
10.1371/JOURNAL.PONE.0005445
P407
P577
2009-05-06T00:00:00Z